Cargando…

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age

Please cite this paper as: Belshe et al. (2010). Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age. Influenza and Other Respiratory Viruses 4(3), 141–145. Background It has been suggested that live attenuated influenza vaccine (LAIV) may be less effective in olde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belshe, Robert B., Toback, Seth L., Yi, Tingting, Ambrose, Christopher S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941661/ https://www.ncbi.nlm.nih.gov/pubmed/20409210 http://dx.doi.org/10.1111/j.1750-2659.2009.00124.x

Ejemplares similares

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults
por: Ambrose, Christopher S., et al.
Publicado: (2010)

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing
por: Ambrose, C. S., et al.
Publicado: (2012)

An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2–17 years
por: Ambrose, Christopher S., et al.
Publicado: (2011)

Maternal outcomes among pregnant women receiving live attenuated influenza vaccine
por: Toback, Seth L., et al.
Publicado: (2011)

No Clinical Association of Live Attenuated Influenza Virus with Nasal Carriage of Bacteria or Acute Otitis Media
por: Coelingh, Kathleen L., et al.
Publicado: (2014)

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
por: Ambrose, Christopher S., et al.
Publicado: (2008)

A multi‐season national estimate of adult influenza vaccination by US office‐based pediatricians, 2006–2011
por: Toback, Seth. L., et al.
Publicado: (2011)

Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing
por: Ambrose, Christopher S.
Publicado: (2012)

Factors associated with in-office influenza vaccination by U.S. pediatric providers
por: Lin, Chyongchiou Jeng, et al.
Publicado: (2013)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
por: Kalappanavar, Nijalingappa K., et al.
Publicado: (2022)

Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016–2017 through 2019–2020 influenza seasons
por: Hu, Wenping, et al.
Publicado: (2021)

Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens
por: Jang, Hyesun, et al.
Publicado: (2018)

Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines
por: Woo, Jennifer C., et al.
Publicado: (2009)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
por: Gilbert, Peter B, et al.
Publicado: (2019)

The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2‐18 years: Results of two phase 3 studies
por: Mallory, Raburn M., et al.
Publicado: (2018)

Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial
por: Ojeda, Joyce, et al.
Publicado: (2019)

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
por: Rudenko, Larisa, et al.
Publicado: (2018)

Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines
por: Ambrose, Christopher S, et al.
Publicado: (2016)

Incidence of live-attenuated influenza vaccine administration beyond expiry date in children and adolescents aged 2–17 years in the UK: a population-based cohort study
por: Caspard, Herve, et al.
Publicado: (2017)

Streptococcus pyogenes Colonization in Children Aged 24–59 Months in the Gambia: Impact of Live Attenuated Influenza Vaccine and Associated Serological Responses
por: Keeley, Alexander J, et al.
Publicado: (2023)

Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16
por: Boddington, Nicki L., et al.
Publicado: (2022)

2015–2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States
por: Poehling, Katherine A, et al.
Publicado: (2018)

1401. Real-World Effectiveness of Inactivated and Live Attenuated Influenza Vaccines in Children During Three Recent Seasons: 2016–2019
por: Bandell, Allyn, et al.
Publicado: (2020)

Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis
por: Caspard, Herve, et al.
Publicado: (2017)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Immune responses after live attenuated influenza vaccination
por: Mohn, Kristin G.-I., et al.
Publicado: (2018)

Novel Approaches for The Development of Live Attenuated Influenza Vaccines
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study
por: Baxter, Roger P., et al.
Publicado: (2018)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
por: Perego, Giulia, et al.
Publicado: (2021)

Prior vaccinations improve immunogenicity of inactivated influenza vaccine in young children aged 6 months to 3 years: A cohort study
por: Ito, Kazuya, et al.
Publicado: (2018)

Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination
por: Lumley, S, et al.
Publicado: (2013)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Live Attenuated Influenza Vaccines by Computer-Aided Rational Design
por: Mueller, Steffen, et al.
Publicado: (2010)

Principles underlying rational design of live attenuated influenza vaccines
por: Jang, Yo Han, et al.
Publicado: (2012)

DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
por: Houser, Katherine V., et al.
Publicado: (2018)

Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6–35 Months
por: Lee, Jee Hyun, et al.
Publicado: (2019)

Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs
por: Holzer, Barbara, et al.
Publicado: (2019)

Bordetella bronchiseptica Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge
por: Hughes, Holly R., et al.
Publicado: (2018)

Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season
por: Pebody, Richard, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c48hru7mlk0kfes440epd2dn5u